Scoop: Sanofi quietly ties up with a low-profile, preclinical cancer biotech — FTC signs off
Sanofi CEO Paul Hudson is building up the oncology cupboard.
The FTC noted on Tuesday that it has approved a deal between Sanofi — listed as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
